Medable
new logos-02.png

Tufts CSDD Innovation Evidence Workshop 
Sponsored by Medable 


March 4, 2026 | Washington, D.C.

Workshop 10AM-5PM | Reception to follow

The Tufts Center for the Study of Drug Development (CSDD), in collaboration with Medable, is hosting and facilitating an Innovation Evidence Workshop. This one-day, invitation-only, workshop brings together pharmaceutical R&D executives and regulatory representatives to examine and discuss new evidence on the use and impact of virtual and remote clinical trial technologies, experience with AI/Agentic-AI-enabled processes supporting clinical research, and challenges and opportunities deploying transformative innovations while adhering to ICH E6 R3 guidelines.

Attendance is limited in this closed-door event to foster candid, substantive and lively discussion. Please register to receive more information and hold your place.

Tufts Agenda 2026-01 (1).jpg


Book a meeting

Schedule a meeting or demo with our platform experts at our DIA booth.

Limited spots - register now!


Meet the Medable team


Chief Executive Officer
Michelle Longmire
Leads Medable’s vision for Agent Studio, driving innovation in AI-powered clinical trial automation and ensuring our platform transforms research into faster, more inclusive, and patient-centric outcomes.
SVP of Global Enterprise Sales
Dave Orrico
Discuss your DCT and enterprise solutions for pharma and biotech.
Executive GM, Customer Value
Andrew Mackinnon
Discuss on eConsent, Site adoption AI, and the latest Duke University Base Lab pilot study results.
Senior Vice President, Enterprise Sales
Tyler Pugsley
Guides enterprise organizations in harnessing Agent Studio to accelerate trial delivery, optimize site engagement, and unlock scalable AI-driven efficiencies in their research pipelines.
SVP, Corporate Development & Investor Relations
Burak Over
Builds strategic partnerships and drives Medable’s corporate development initiatives while managing investor relations. Connect with Burak to learn how Medable aligns long-term growth strategy with innovation in decentralized and digital trials.

VP, Product Management
Luke Bates
Leads product strategy and innovation at Medable, ensuring our platform evolves to meet the needs of sponsors, CROs, and sites. Luke brings deep expertise in designing scalable, patient-centric solutions that accelerate digital trial adoption.
VP, New Markets
Aadhar Shah
Expands Medable’s global reach by driving adoption of decentralized trial solutions in emerging markets. Aadhar specializes in helping sponsors and CROs navigate new geographies with flexible, enterprise-ready digital platforms.
Solution Consultant
Rj Lozano
Meet to receive a product demo for Total Consent, eCOA+ and more.

Agentic AI & The Future of Clinical Research

Join us to discover how Agentic AI is poised to fundamentally reshape the future of clinical research. This presentation will move beyond theory to showcase how intelligent, autonomous agents are being deployed today to automate workflows, accelerate trials, and drive unprecedented efficiency. You'll gain a clear understanding of the immediate and future impact of this technology on your work.
  • AI Zone Theatre A
  • Monday, October 20th
  • 3:15-3:35 PM
  • 20 minutes
OCT

20

Michelle Longmire
MEDABLE
Co-Founder and CEO

Angela DeLuca
TAKEDA
Vice President, Head of Oncology & Cell Therapies Clinical Operations, Global Development Office, R&D

Michael Greeley
Flare Capital Partners
Co-Founder & General Partner, Healthcare Technology

AI Agents: A Superpower for Clinical Research

Discover how AI agents are transforming clinical research from a tool to a true partner, giving clinical professionals the power to accelerate trials. We'll show you real-world use cases where these autonomous agents are being deployed to streamline workflows and drive efficiency on the front lines. You'll leave with a clear understanding of how this technology can be harnessed to supercharge your own research efforts.
  • AI Zone Theatre C
  • Tuesday, October 21st
  • 10:15AM-10:35AM
  • 20 minutes
OCT

21

Andrew Mackinnon
MEDABLE
Executive GM, Customer Value
Luke Bates
MEDABLE
VP, Product Management
Special Guest
TBA
TBA

SESSION HIGHLIGHT

Responsibility and Oversight in Decentralized Clinical Trials

Join Medable’s CSO, Pamela Tenaerts to discuss issues that drive principal investigator (PI) oversight and responsibility in modern clinical trials where research and data gathering activities are no longer confined to the traditional site model.
Wed, June 28 | 10:30-11:30am

ROUNDTABLE DISCUSSION

RWD: Maximizing Value and Quality through End-to-End Patient Centricity

Join Medable’s VP, Digital Transformation Strategy, Reem Yunis and Walgreen’s Head, Digital Optimization, RWE Clinical Trials, Kendal Whitlock for a follow up roundtable discussion tied to session: Real-World Data: Maximizing Value and Quality through End-to-End Patient Centricity.
Wed, June 28 | 1:15-2:15pm
You’re on the list.
Somebody will reach out to you soon to schedule a sneak peek of our upcoming product features and capabilities. In the meantime, enjoy our latest content about the future of clinical trials.
EXPLORE CONTENT

You’re invited! Join Medable at our reception.

RSVP here
Unified clinical trials.
  • Privacy Policy
  • Legal
  • © 2023 Medable Inc. All rights Reserved